NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
183 hedge funds and large institutions have $2.97B invested in NEVRO CORP. in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 69 increasing their positions, 65 reducing their positions, and 36 closing their positions.
28% more call options, than puts
Call options by funds: $25.2M | Put options by funds: $19.7M
24% more capital invested
Capital invested by funds: $2.4B → $2.97B (+$567M)
6% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 65
9% less funds holding
Funds holding: 201 → 183 (-18)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
47% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 36
Top Buyers
| 1 |
BlackRock
New York
|
+$59.8M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$54.3M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$50.6M |
| 4 |
Bank of New York Mellon
New York
|
+$19.5M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$19.2M |
Top Sellers
NVRO Hedge Fund Activity: Q3 2017 in Review
183 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2017, worth a combined $2.97B — up 24% from $2.4B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of NVRO and 19 opened new positions — a net loss of 17 holders — while 65 trimmed existing stakes and 69 added.
The largest buyer was BlackRock, adding an estimated $59.8M. The largest seller was Fidelity Investments, cutting an estimated $80.6M.
- 183 institutional investors held NEVRO CORP. (NVRO) as of Q3 2017, down from 201 in Q2 2017.
- Funds reported $2.97B of NEVRO CORP. stock for Q3 2017, up 24% quarter-over-quarter.
- 19 funds opened new NEVRO CORP. positions in Q3 2017 and 36 closed out, a net change of -17 holders.
- The largest NEVRO CORP. buyer in Q3 2017 was BlackRock, an estimated $59.8M added.
- The largest NEVRO CORP. seller in Q3 2017 was Fidelity Investments, an estimated $80.6M sold.
Based on aggregated 13F filings for Q3 2017.